From Medscape Oncology

Coverage From The

American Society of Clinical Oncology (ASCO) 2019 Annual Meeting

May 31 - June 04, 2019; Chicago, Illinois

May 31 - June 04, 2019 Chicago, Illinois

Medscape Booth #3134

ASCO 2019 Unique Emotional Challenges Faced by Oncologists Physicians have the highest suicide rate of any profession, and oncology providers face unique emotional challenges because of their specialty.
Medscape Medical News, July 4, 2019
ASCO 2019 Robotic Surgery vs Radiation in Oropharyngeal Cancer The only trial directly comparing the two modalities found better swallowing outcomes with radiotherapy, but no difference in survival.
Medscape Medical News, June 12, 2019
ASCO 2019 Oncologists Are Engaging Less With Industry Since Open Payments Fewer oncologists are receiving industry payments since the inception of the Open Payments program, but spending has not decreased and appears to have shifted.
Medscape Medical News, June 7, 2019

Meeting Highlights At A Glance

Top News From ASCO 2019: Slideshow Highlights include potentially practice-changing data on immunotherapy for head and neck cancer, as well as new data for breast, lung, prostate and pancreatic cancer.

Conference News

ASCO 2019 Unique Emotional Challenges Faced by Oncologists
Medscape Medical News, July 4, 2019
ASCO 2019 A Journey Into Cancerland
Medscape Medical News, June 20, 2019
ASCO 2019 Hashtag Medicine: Abstract Tweeted at ASCO Ignites Debate
Medscape Medical News, June 13, 2019
ASCO 2019 Immunotherapies Can Kill Money Bonuses in OC Model
Medscape Medical News, June 13, 2019
ASCO 2019 Premenopausal Women With Breast Cancer; New TAILORx Data
Medscape Medical News, June 12, 2019
ASCO 2019 Robotic Surgery vs Radiation in Oropharyngeal Cancer
Medscape Medical News, June 12, 2019
ASCO 2019 Cancer Patients School Clinicians About Marijuana
Medscape Medical News, June 10, 2019
ASCO 2019 Oncologists Are Engaging Less With Industry Since Open Payments
Medscape Medical News, June 7, 2019
ASCO 2019 One-Way Texting: No Help with Breast Cancer Pill Taking, But…
Medscape Medical News, June 7, 2019
ASCO 2019 Liquid Biopsies Predict Early ER+ Breast Cancer Progression
Medscape News UK, June 7, 2019
ASCO 2019 No Survival Benefit With Immunotherapy in TN Breast Cancer
Medscape Medical News, June 6, 2019
ASCO 2019 Diamonds Are Forever, but TKIs in CML Don't Have to Be
Medscape Medical News, June 6, 2019
ASCO 2019 Less Toxicity With Proton Beam vs Photon Chemoradiotherapy
Medscape Medical News, June 6, 2019
ASCO 2019 TITAN Solidifies Place for Apalutamide in Metastatic CSPC
Medscape Medical News, June 6, 2019
ASCO 2019 More Is Not Better in Metastatic CR Prostate Cancer
Medscape Medical News, June 5, 2019
ASCO 2019 Is Active Surveillance for Prostate Cancer Safe?
Medscape Medical News, June 5, 2019
ASCO 2019 Novel Drug for Advanced Urothelial Cancer: Enfortumab Vedotin
Medscape Medical News, June 5, 2019
ASCO 2019 Cancer Bone Mets Therapy: One in 40 Patients at Risk for ONJ
Medscape Medical News, June 5, 2019
ASCO 2019 Free Online Tool Predicts Late ER+ Breast Cancer Recurrence
Medscape News UK, June 5, 2019

ASCO 2019 Score One for Minimally Invasive Cancer Surgery
Medscape Medical News, June 3, 2019
ASCO 2019 Sexual Harassment Reported by 64% of Gynecologic Oncologists
Medscape Medical News, June 3, 2019
ASCO 2019 New First-Line Option in Head and Neck Cancer: 'Practice Changing'
Medscape Medical News, June 3, 2019
ASCO 2019 Misleading Advertising Claims by Proton Beam Therapy Centers
Medscape Medical News, June 3, 2019
ASCO 2019 Enzalutamide Joins Initial Tx List for Metastatic Prostate Cancer
Medscape Medical News, June 3, 2019
ASCO 2019 ACA Medicaid Expansion Reduces Disparities in Cancer Care
Medscape Medical News, June 2, 2019
ASCO 2019 Olaparib Delays Progression in BRCA Pancreatic Cancer
Medscape Medical News, June 2, 2019
ASCO 2019 'Surgery Is Never Elegant When Women Are in the OR'
Medscape Medical News, June 2, 2019
ASCO 2019 'Chemoboy' Takes Center Stage at ASCO Meeting
Medscape Medical News, June 1, 2019
ASCO 2019 First CDK4/6 Inhibitor to Improve Survival in Metastatic Breast Cancer
Medscape Medical News, June 1, 2019
ASCO 2019 1-in-4 NSCLC Patients Alive at 5 Years After Pembrolizumab
Medscape Medical News, June 1, 2019
Pembro Noninferior, Less Toxic Than Chemo in Gastric Cancer
Medscape Medical News, June 1, 2019
ASCO 2019 Using ASCO's Clinical Database for Commercial Research Raises Questions
Medscape Medical News, May 31, 2019
ASCO 2019 Hashtag Medicine: Tweeting at ASCO
Medscape Medical News, May 31, 2019
ASCO 2019 What's Happening at ASCO 2019?
Medscape Medical News, May 21, 2019
ASCO 2019 Lenalidomide Delays Onset of Multiple Myeloma
Medscape Medical News, May 20, 2019
ASCO 2019 Now Evidence Supports Reducing Chemo in Frail Elderly Patients
Medscape Medical News, May 20, 2019
ASCO 2019 'Striking' Responses in Pediatric Solid Tumors With Entrectinib
Medscape Medical News, May 16, 2019
ASCO 2019 Reduced-Fat, Balanced Diet May Cut Death Risk From Breast Cancer
Medscape Medical News, May 16, 2019

Medscape Oncology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Peer-to-Peer Discussions

Guiding Patients to and Through Second Opinions
Debra A. Patt, MD, MPH, MBA; Bradford R. Hirsch, MD, MBA
What Matters Most to Oncology Patients?
Lidia Schapira, MD; Ethan Basch, MD
Is the 'Value' Movement Affecting Everyday Oncology Practice?
Kathy D. Miller, MD; Leonard B. Saltz, MD; Lee S. Schwartzberg, MD
Balancing the Dark Days in Oncology
Don S. Dizon, MD; Susana M. Campos, MD, MPH
Navigating the Challenges of Prior Authorization
Debra A. Patt, MD, MPH, MBA; Ethan M. Basch, MD, MSc
'The Cancer in Bed Two': Why Language Matters in Medicine
Don S. Dizon, MD; Tatiana M. Prowell, MD
From Oncology Care to Primary Care: Reassuring Survivors
Lidia Schapira, MD; Neelima Denduluri, MD
Breast Cancer at ASCO 2019: IO, CDK4/6i,
Kathy D. Miller, MD; Harold J. Burstein, MD, PhD
'Mind-boggling' IO Data, Plus New Combos, Targets for NSCLC
H. Jack West, MD; Charu Aggarwal, MD; Sandip P. Patel, MD

Expert Perspectives

Setbacks and Advances in Renal Cell Carcinoma Treatment
Evan T. Hall, MD, MPhil
De-escalating Cancer Therapy: More Talk Than Action?
Ravi B. Parikh, MD, MPP
'A Really Big Year' for Lung Cancer Treatment
Mark G. Kris, MD
Exceeding Our Patients' Expectations Needs to Be the Goal Now
Mark G. Kris, MD
Early Breast Cancer Highlights From ASCO 2019
Harold J. Burstein, MD, PhD
Notion of Academic and Community Oncology 'Tribes' Needs to End
H. Jack West, MD; Edward B. Garon, MD, MS; Mark A. Lewis, MD
ASCO: Ain't Nothing Like the Real Thing, Baby
H. Jack West, MD

Video Commentaries

Does Cannabis Have a Role in Cancer Management?
Mellar P. Davis, MD
Reporting Adverse Drug Events Has Chilling Effect
Ashley Godwin
Why Do Some Cancer Prescriptions Encounter Delays?
Daniel O'Neil, MD, MPH

Meeting Previews

Your First ASCO: Remember, the Goal Is to Feel Inspired
Bishal Gyawali, MD, PhD
How to Avoid ASCO's 'Weird,' 'Wall Street' Feel
David J. Kerr, MD, DSc

Popular News from ASCO 2018

'Cancer Is Almost Always a Crisis' Cancer patients are particularly vulnerable to psychosocial distress as a result of both the diagnosis and treatment, which can affect treatment decisions. But how can this burden best be tackled?
Medscape Medical News, Jul 05, 2018
Chemo Not Needed for Most Early Breast Cancer: TAILORx Practice-changing results from the TAILORx trial have confirmed that about 70% of patients with hormone-positive early breast cancer will not benefit from adjuvant chemotherapy.
Medscape Medical News, Jun 03, 2018
'Oncologists Can Feel Optimistic,' Says NCI Director In announcing $10 million in new funding for cancer clinical trials, the NCI director told a packed hall of oncologists that there is 'enormous optimism in our field.
Medscape Medical News, Jun 03, 2018

Previous Coverage